EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

A Comparative Study of Melittins from Apis florea and Apis mellifera as Cytotoxic Agents Against Non-Small Cell Lung Cancer (NSCLC) Cells and Their Combination with Gefitinib

Pachara Sattayawat iD, Thida Kaewkod iD, Saruda Thongyim, Chutipa Chiawpanit, Yupanun Wutti-In iD, Chutamas Thepmalee, Yingmanee Tragoolpua iD, Terd Disayathanoowat iD, Aussara Panya

International Journal of Molecular Sciences · 11.03.2025 · 26 (6) · 2498

DOI: 10.3390/ijms26062498 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.03.2025. Verfasst von Pachara Sattayawat und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Gefitinib, Lung Neoplasms, Melitten. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chiang Mai University, Fundamental Fund 2024, Chiang Mai University, Chiang Mai Universit.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer remains one of the most lethal malignancies, often diagnosed at advanced stages, leading to limited treatment options. Thus, identifying natural products with potent anti-cancer activity is crucial for improving treatment outcomes. While the melittin from Apis mellifera (Mel-AM) has been extensively studied, the melittin from Apis florea (Mel-AF), a bee species native to Southeast Asia, remains relatively underexplored. These peptides were comparatively investigated against non-small cell lung cancer (NSCLC) cell lines, A549, NCI-H460, and NCI-H1975. Mel-AF demonstrated a superior cytotoxicity (cytotoxic concentration 50% (CC50) = 2.55–5.06 µg/mL) compared to Mel-AM (CC50 = 4.32–8.48 µg/mL). While both peptides induced apoptosis via the intrinsic mitochondrial pathway, Mel-AF exhibited a more pronounced effect, significantly enhancing apoptosis induction compared to Mel-AM. Both peptides inhibited cell migration and invasion; however, when combined with gefitinib, Mel-AF more effectively enhanced the drug’s inhibitory effects on the A549 and NCI-H460 cell lines compared to Mel-AM, underscoring its superior potential as a therapeutic agent. Altogether, we demonstrated that these peptides induced apoptosis in NSCLC cell lines, with Mel-AF having more pronounced effects, and the combination use of peptides with a chemotherapeutic drug showed synergistic effects against lung cancer cells, enhancing their practical use in lung cancer treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungGefitinibLung NeoplasmsMelittenAntineoplastic AgentsHumansAnimalsBeesApoptosisCell Line, TumorCell MovementA549 CellsCell ProliferationCell Survival

Stichwörter der Autor:innen

EGFRNSCLCanti-cancer peptidesbee venommelittin

Substanzen

GefitinibMelittenAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Cell Engineering for Cancer Therapy Research Group, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Research Center of Deep Technology in Beekeeping and Bee Products for Sustainable Development Goals (SMART BEE SDGs), Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Office of Research Administration, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Division of Biochemistry, School of Medical Sciences, University of Phayao, Phayao 56000, Thailand.

ORCID-Profile: Pachara Sattayawat, Thida Kaewkod, Yupanun Wutti-In, Yingmanee Tragoolpua, Terd Disayathanoowat

Förderung

  • Chiang Mai University
  • Fundamental Fund 2024, Chiang Mai University
  • Chiang Mai Universit

Zitieren

APA

Sattayawat, P., Kaewkod, T., Thongyim, S., Chiawpanit, C., Wutti-In, Y., Thepmalee, C., Tragoolpua, Y., Disayathanoowat, T., & Panya, A. (2025). A Comparative Study of Melittins from Apis florea and Apis mellifera as Cytotoxic Agents Against Non-Small Cell Lung Cancer (NSCLC) Cells and Their Combination with Gefitinib. International Journal of Molecular Sciences, 26(6), 2498. https://doi.org/10.3390/ijms26062498

Vancouver

Sattayawat P, Kaewkod T, Thongyim S, Chiawpanit C, Wutti-In Y, Thepmalee C, et al. A Comparative Study of Melittins from Apis florea and Apis mellifera as Cytotoxic Agents Against Non-Small Cell Lung Cancer (NSCLC) Cells and Their Combination with Gefitinib. International Journal of Molecular Sciences. 2025;26(6):2498. doi:10.3390/ijms26062498

BibTeX
@article{Sattayawat2025,
  author = {Sattayawat, Pachara and Kaewkod, Thida and Thongyim, Saruda and Chiawpanit, Chutipa and Wutti-In, Yupanun and Thepmalee, Chutamas and Tragoolpua, Yingmanee and Disayathanoowat, Terd and Panya, Aussara},
  title = {A Comparative Study of Melittins from Apis florea and Apis mellifera as Cytotoxic Agents Against Non-Small Cell Lung Cancer (NSCLC) Cells and Their Combination with Gefitinib},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {6},
  pages = {2498},
  doi = {10.3390/ijms26062498}
}
Kostenlos starten →